Muguka, a leaf-based variant of khat popular across Kenya’s coastal region, has become a genuine flashpoint in the country’s public health debate — praised by some as an affordable social and cultural staple, and flagged by health authorities as a substance with real, documented risks. Understanding what the evidence actually shows helps cut through the political noise surrounding recent ban debates. Here’s what research points to.
What Muguka Actually Is
Muguka is a variant of khat (scientifically Catha edulis), sold as handfuls of leaves harvested from the tips of the plant, distinguishing it from miraa, which consists of longer stems from the same broader plant family. Muguka’s affordability — sold for just a few coins per handful, compared to pricier miraa — has made it a widely used work boost and social pastime, particularly in Kenya’s coastal counties of Mombasa, Kilifi, and Taita Taveta, even as it’s cultivated primarily in the central counties of Embu and its surrounding region.
The Immediate Effects Users Report
Kenya’s National Campaign Against Drug Abuse Authority (NACADA) has documented that muguka consumption produces increased energy, alertness, and enhanced mood in users, along with decreased hunger and fatigue. This is part of what drives its popularity — users commonly report chewing it to extend working hours, socialize, reduce stress, or simply stay alert during long days. Its active compounds, cathinone and cathine, release gradually during chewing, producing a milder stimulant effect than amphetamine in pill or powder form.
Documented Physical Health Effects
Beyond its short-term stimulant effects, NACADA and multiple Kenyan health researchers have documented a consistent set of physical health impacts associated with regular muguka use, including dehydration, reproductive health problems, dental decay and discoloration (with continued long-term use sometimes leading to eventual tooth loss), constipation, insomnia, and dizziness. Research has also linked khat use, including muguka, to nutritional deficiencies and adverse effects on maternal and reproductive health specifically.
Mental Health Effects Are a Growing Concern
Mental health impacts have drawn particular attention from Kenyan health authorities. A study led by prominent Kenyan psychiatrist Prof. Lukoye Atwoli, surveying more than 800 participants in a rural khat-growing and chewing population, found associations between khat chewing and psychotic symptoms, including hallucinations, delusions, and disturbed thought patterns. Broader research has also documented impaired cognitive functioning, anxiety, and dependence among regular users, and rising admissions at mental health and rehabilitation centers in coastal Kenya have been partly attributed to muguka and related substance abuse, particularly among younger users.
Dependence and Withdrawal Are Real Risks
Regular, heavy muguka use can lead to genuine dependence, where users report being unable to function normally without it. Individuals who suddenly stop after developing dependence have reported withdrawal symptoms including nightmares, tremors, depression, sedation, and low blood pressure — a pattern consistent with dependence on other stimulant substances.
Combining Muguka With Other Substances Raises the Risk
A significant concern flagged by both NACADA and the Kenya Medical Association is that muguka is frequently used alongside other substances — alcohol, cannabis, and in some cases diverted prescription sedatives like diazepam, used to intensify its effects. This kind of poly-substance use compounds health risks considerably beyond what muguka alone would cause, and chewing sessions often take place in crowded, poorly ventilated group settings, which health officials have also flagged as raising the risk of communicable diseases like tuberculosis.
The Research Base Still Has Real Gaps
It’s worth being honest about the limits of current evidence: much of the reported data on muguka’s mental and physical health effects comes from limited empirical research rather than large-scale, rigorously controlled studies. The Kenya Medical Association and NACADA have both called for more systematic research — including measuring actual cathinone and cathine concentrations in muguka grown across different regions — to build a stronger scientific basis for public health policy and regulation.
A Genuinely Contested Public Health and Cultural Question
Muguka sits at a real crossroads of competing interests in Kenya. For some communities, particularly among older users, khat carries longstanding cultural and social significance, and it remains an economically important crop — Kenya’s highest-valued horticultural export. For public health officials and medical professionals, the documented health risks, rising youth use, and links to socioeconomic strain (including some users spending a substantial share of household income to sustain use) represent a genuine and growing concern. Debates over whether to ban or more tightly regulate muguka, similar to alcohol and tobacco regulation, remain actively unresolved in Kenyan policy discussions.
Join The Discussion
Whether you’ve used muguka yourself, know someone who has, or you’re simply curious about the ongoing policy debate in Kenya, what’s your perspective on how the country should approach this issue? Share what you’ve observed about its role in your community, or questions you have about the health research discussed here. If muguka or khat use has become something you or someone close to you is struggling to manage, know that NACADA and mental health services in Kenya can offer support beyond what any article can provide.
